Memantine and gait disturbance Patient Reports February 12, 2012

Memantine Side Effects Report #4788187-2
Memantine side effect was reported by a Health Professional from GERMANY on June 30, 2005. Male patient, 77 years of age, was diagnosed with open angle glaucoma and was treated with Memantine. After drug was administered, patient experienced the following side effects: gait disturbance, incorrect dose administered, myoclonus. Memantine dosage: 10 MG QD PO. During the same period patient was treated with ATENOLOL, WARFARIN, MIRTAZAPINE. Patient was hospitalized. Patient recovered.

Memantine Side Effects Report #5692881-9
Memantine side effect was reported by a Consumer or non-health professional from FRANCE on Mar 18, 2008. Female patient, 94 years of age, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: diet refusal, disturbance in attention, gait disturbance, incontinence, somnolence. Memantine dosage: 5 MG QD PO. During the same period patient was treated with LEVOTHYROXINE, INDAPAMIDE, DILTIAZEM HYDROCHLORIDE. Patient recovered.

Memantine Side Effects Report #5150743-X
Memantine side effect was reported by a Health Professional from JAPAN on Oct 31, 2006. Male patient, 92 years of age, weighting 128.1 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: cerebral infarction, depressed level of consciousness, fall , gait disturbance, restlessness, somnolence. Memantine dosage: unknown. During the same period patient was treated with PITAVASTATIN CALCIUM, NICERGOLINE, DENOPAMINE, DIGESTIVE ENZYME PREPARATIONS, FAMOTIDINE, CITICOLINE, CYANOCOBALAMIN, THIAMINE DISULFIDE NITRATE. Patient was hospitalized. Patient recovered.

Memantine Side Effects Report #5759053-0
Memantine side effect was reported by a Consumer or non-health professional from FRANCE on May 16, 2008. Female patient, 86 years of age, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: electroencephalogram abnormal, epilepsy , gait disturbance, somnolence, tremor. Memantine dosage: 20 MG QD PO. During the same period patient was treated with ATHYMIL, RISPERDAL, IMOVANE, KARDEGIC. Patient recovered.


Memantine Side Effects Report #5762092-7
Memantine side effect was reported by a Health Professional from GERMANY on May 16, 2008. Female patient, 86 years of age, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: electroencephalogram abnormal, epilepsy , gait disturbance, somnolence, tremor. Memantine dosage: 20 MG QD PO. During the same period patient was treated with ATHYMIL, RISPERDAL, IMOVANE, KARDEGIC. Patient recovered.

Memantine Side Effects Report #5906779-1
Memantine side effect was reported by a Consumer or non-health professional from GERMANY on Sept 16, 2008. Female patient, 85 years of age, weighting 127.9 lb, was diagnosed with dementia alzheimer's type, sleep disorder , lipids abnormal and was treated with Memantine. After drug was administered, patient experienced the following side effects: aphasia , dehydration, electroencephalogram abnormal, epilepsy , faecaloma, gait disturbance, hyperhidrosis, hypertonia, metabolic syndrome . Memantine dosage: 20 MG (10 MG, 2 IN 1 D), ORAL. During the same period patient was treated with ATHYMIL, ZOCOR, RISPERDAL, EFFERALGAN CODEIN. Patient recovered.

Memantine Side Effects Report #5203507-2
Memantine side effect was reported by a Health Professional from FRANCE on Dec 20, 2006. Male patient, 84 years of age, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: abnormal behaviour, apathy, condition aggravated, dyspraxia, gait disturbance, mood swings, speech disorder. Memantine dosage: 10 MG BID PO. During the same period patient was treated with ARICEPT, CITALOPRAM HYDROBROMIDE, KARDEGIC, SECTRAL, PRAVASTATIN, RABEPRAZOLE. Patient recovered.

Memantine Side Effects Report #5172435-3
Memantine side effect was reported by a Health Professional from FRANCE on Nov 14, 2006. Male patient, 84 years of age, weighting 136.7 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: bedridden, dysstasia, gait disturbance, somnolence. Memantine dosage: 5 MG QD PO. During the same period patient was treated with DILTIAZEM HYDROCHLORIDE, ASPIRIN, CITALOPRAM HYDROBROMIDE, ATARAX. Patient recovered.

Memantine Side Effects Report #6023205-5
Memantine side effect was reported by a Pharmacist from GERMANY on Sept 30, 2008. Female patient, 84 years of age, weighting 88.18 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: balance disorder, gait disturbance. Memantine dosage: 10 MG (10 MG, 1 IN 1 D), ORAL. During the same period patient was treated with BETA BLOCKING AGENTS. Patient recovered.


Memantine Side Effects Report #5072876-9
Memantine side effect was reported by a Health Professional from JAPAN on July 21, 2006. Male patient, 83 years of age, weighting 116.8 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: activities of daily living impaired, gait disturbance. Memantine dosage: unknown. During the same period patient was treated with INSULIN, MECOBALAMIN, LIMAPROST ALFADEX. Patient was hospitalized. Patient recovered.

Memantine Side Effects Report #5599300-1
Memantine side effect was reported by a Consumer or non-health professional from GERMANY on Jan 03, 2008. Male patient, 82 years of age, weighting 174.2 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: abdominal pain , condition aggravated, depression , dizziness , gait disturbance, malaise, transaminases increased. Memantine dosage: 10 MG QD PO. During the same period patient was treated with PAROXETINE, EQUANIL, ZOPICLONE, TAMSULOSIN. Patient recovered.

Memantine Side Effects Report #5102577-X
Memantine side effect was reported by a Health Professional from JAPAN on Aug 24, 2006. Male patient, 80 years of age, weighting 121.5 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: amnesia, condition aggravated, gait disturbance, lung disorder, pleurisy, pneumonia , tachycardia, wheezing. Memantine dosage: 20 MG QD PO. During the same period patient was treated with TOCOPHEROL NICOTINATE, UBIDECARENONE, NAFTOPIDIL, SENNOSIDE. Patient was hospitalized. Patient recovered.

Memantine Side Effects Report #5107768-X
Memantine side effect was reported by a Consumer or non-health professional from GERMANY on Sept 07, 2006. Male patient, 80 years of age, weighting 121.5 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: amnesia, body height increased, condition aggravated, gait disturbance, hypoxia, lung disorder, pleural calcification, pyothorax, tachycardia. Memantine dosage: 20 MG QD PO. During the same period patient was treated with TOCOPHEROL NICOTINATE, UBIDECARRENONE, NAFTOPIDIL, SENNOSIDE. Patient was hospitalized. Patient recovered.

Memantine Side Effects Report #5989669-8
Memantine side effect was reported by a Pharmacist from GERMANY on Nov 28, 2008. Female patient, 80 years of age, weighting 86.20 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: abasia, blood alkaline phosphatase increased, dizziness , electroencephalogram abnormal, gait disturbance, hepatic atrophy, hyperammonaemia, loss of consciousness. Memantine dosage: 20 MG (20 MG, 1 IN 1 D), ORAL. Patient was hospitalized. Patient recovered.


Memantine Side Effects Report #5946211-5
Memantine side effect was reported by a Pharmacist from GERMANY on Nov 03, 2008. Male patient, 79 years of age, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: dystonia , gait disturbance, pleurothotonus. Memantine dosage: unknown. During the same period patient was treated with EXELON. Patient was hospitalized. Patient died on 08/01/2005.

Memantine Side Effects Report #5023108-9
Memantine side effect was reported by a Health Professional from FRANCE on May 18, 2006. Male patient, 79 years of age, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: abnormal behaviour, condition aggravated, disorientation, fall , gait disturbance, hydrocephalus , ill-defined disorder, incontinence, memory impairment. Memantine dosage: 10 MG BID PO. During the same period patient was treated with EFFEXOR, REMINYL. Patient was hospitalized. Patient recovered.

Memantine Side Effects Report #5029064-1
Memantine side effect was reported by a Consumer or non-health professional from GERMANY on June 08, 2006. Male patient, 79 years of age, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: abnormal behaviour, disorientation, fall , gait disturbance, hydrocephalus , incontinence, memory impairment. Memantine dosage: 10 MG BID PO. During the same period patient was treated with EBIXA, EFFEXOR, REMINYL. Patient was hospitalized. Patient recovered.

Memantine Side Effects Report #5532163-9
Memantine side effect was reported by a Health Professional from GERMANY on Nov 13, 2007. Male patient, 76 years of age, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: cerebral infarction, confusional state, fall , femoral neck fracture, gait disturbance. Memantine dosage: unknown. During the same period patient was treated with CITALOPRAM HYDROBROMIDE, OPTIMOL, SPARKAL, IDEOS, BETOLVIDON, XATRAL. Patient was hospitalized. Patient recovered.

Memantine Side Effects Report #5173225-8
Memantine side effect was reported by a Health Professional from BELGIUM on Nov 27, 2006. Male patient, 75 years of age, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: abnormal behaviour, aggression, agitation, blood glucose increased, cholecystitis acute, depressed level of consciousness, gait disturbance, glabellar reflex abnormal, glycosylated haemoglobin increased. Memantine dosage: 10 MG BID PO. During the same period patient was treated with LACRYSTAT, PRANOX, ACETYLSALICYLIC ACID SRT, PERSANTINE, CITALOPRAM HYDROBROMIDE, TRAZOLAM, PANTOZOL, DIAMICRON. Patient was hospitalized. Patient recovered.


Memantine Side Effects Report #5328629-7
Memantine side effect was reported by a Consumer or non-health professional from ITALY on Apr 27, 2007. Female patient, 73 years of age, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: agitation, cerebral atrophy, condition aggravated, gait disturbance, hallucination, visual. Memantine dosage: 5 MG QD PO. During the same period patient was treated with PAROXETINE, GALANTAMINE HYDROBROMIDE, QUETIAPINE FUMARATE, VITAMIN E. Patient was hospitalized. Patient recovered.

Memantine Side Effects Report #5786691-1
Memantine side effect was reported by a Consumer or non-health professional from FRANCE on June 11, 2008. Male patient, 87 years of age, weighting 121.3 lb, was diagnosed with dementia  and was treated with Memantine. After drug was administered, patient experienced the following side effects: bedridden, blood albumin decreased, gait disturbance, malnutrition, pulmonary embolism . Memantine dosage: 20 MG QD PO. During the same period patient was treated with STABLON, EQUANIL, BRICANYL, PULMICORT, IMOVANE. Patient died on 03/24/2008.

Memantine Side Effects Report #6141293-2
Memantine side effect was reported by a Health Professional from GERMANY on Mar 18, 2009. Female patient, 93 years of age, was treated with Memantine. After drug was administered, patient experienced the following side effects: atrioventricular block first degree, fall , gait disturbance, sinus bradycardia, syncope. Memantine dosage: 10 MG (10 MG,1 IN 1 D),ORAL. During the same period patient was treated with CORDARONE, XALACOM, TRUSOFT. Patient was hospitalized. Patient recovered.

Memantine Side Effects Report #5679313-1
Memantine side effect was reported by a Consumer or non-health professional from GERMANY on Mar 06, 2008. Female patient, 45 years of age, was treated with Memantine. After drug was administered, patient experienced the following side effects: gait disturbance, grand mal convulsion. Memantine dosage: 10 MG QD PO. Patient recovered.

Memantine Side Effects Report #5648753-9
Memantine side effect was reported by a Consumer or non-health professional from GERMANY on Feb 13, 2008. Female patient, child 4 years of age, was treated with Memantine. After drug was administered, patient experienced the following side effects: blood creatine increased, c-reactive protein increased, disturbance in attention, eosinophil percentage decreased, gait disturbance, lymphocyte percentage decreased, mean cell haemoglobin decreased. Memantine dosage: unknown. During the same period patient was treated with CAPTOPRIL. Patient was hospitalized. Patient recovered.


Memantine Side Effects Report #5739701-1
Memantine side effect was reported by a Consumer or non-health professional from GERMANY on Apr 28, 2008. Female patient, child 4 years of age, was treated with Memantine. After drug was administered, patient experienced the following side effects: blood creatine increased, c-reactive protein increased, disturbance in attention, electroencephalogram abnormal, eosinophil percentage decreased, gait disturbance, lymphocyte percentage decreased. Memantine dosage: unknown. During the same period patient was treated with CAPTOPRIL. Patient was hospitalized. Patient recovered.

Memantine Side Effects Report #5878511-1
Memantine side effect was reported by a Consumer or non-health professional from GERMANY on Aug 26, 2008. Male patient, child 3 years of age, was treated with Memantine. After drug was administered, patient experienced the following side effects: dizziness , gait disturbance, somnolence. Memantine dosage: unknown. Patient was hospitalized. Patient recovered.